nDatalyze Corp. Announces Adoption of Semi-Annual Financial Reporting Trial, provides a progress report on the potential RTO, and updates the Epitome sports performance assessment project

CALGARY, AB – TheNewswire – March 26, 2026 – nDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the “Company” or “nDatalyze”) is pleased to announce its intention to participate in the Semi-Annual Reporting (“SAR”) Pilot Program recently adopted by the Canadian Securities Administrators (CSA), provides a progress report on the potential RTO, and updates the Epitome sports performance assessment project.

The SAR Pilot: Implemented through Coordinated Blanket Order 51-933, allows eligible venture issuers listed on the Canadian Securities Exchange (CSE) to voluntarily move from a quarterly to a semi-annual financial reporting framework. By adopting the SAR, nDatalyze aims to reduce the administrative and financial burden associated with quarterly reporting, allowing management to focus more resources on its core technology-driven mental health solutions.

Transition Details – nDatalyze’s fiscal year ends on February 28. Under the SAR Pilot, the Company will be exempt from filing interim financial reports and related Management’s Discussion & Analysis (MD&A) for its first and third quarters.

• Initial Interim Period: The Company will not file an interim report for the first quarter (Q1) ending May 31, 2026. 

• Ongoing Reporting: nDatalyze will continue to file audited annual financial statements (due within 120 days of February 28) and six-month interim financial reports (due within 60 days of August 31). 

• Continued Disclosure: The Company remains committed to timely disclosure and will continue to report all material changes and significant developments as required under National Instrument 51-102. 

Eligibility – nDatalyze confirms it meets the pilot program’s eligibility criteria, which include being a venture issuer with annual revenues of less than $10 million and maintaining a clean 12-month continuous disclosure record.

RTO update: The Company has been informed by the RTO target, Prism Diversified Ltd., that its pre-RTO financing is proceeding and that it expects to be in a position to execute a definitive agreement in the near future. Based on the Prism report, the Company feels confident that the RTO will proceed.

The Epitome sports performance assessment project: The Commercialization report is now complete. This report was meant to inform the marketing approach and involved executive-level input from three highly regarded hockey schools/academies, those being ALPS Hockey Academy (Italy), MacLauchlan College (Canada), Okanagan Hockey (Canada). As a result of the feedback, the Company is confident in the priority order of Epitome’s target markets, the classification of person (scout, coach, JV partner) who is best positioned to penetrate those markets, what the pricing/pricing structure needs to include, and the seasonality of the sales cycle. With this data in hand, the Company is now considering its commercialization options and will report as things progress.

About nDatalyze Corp.

nDatalyze Corp. generates technology-based, health/performance-related solutions using advanced AI and biometric data analysis.

For Further Information, please contact:

Jim Durward, President, CEO/CTO

Email: [email protected]  

Tel: (403) 689-3901

nDatalyze Website: https://www.ndatalyze.com      

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

Copyright (c) 2026 TheNewswire – All rights reserved.